NextechLabs
Finnrick has tested 31 samples from NextechLabs across 6 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Ipamorelin | 4 | 27 Feb 2025 | 20 Mar 2025 | |||||
| Retatrutide | 8 | 14 Jan 2025 | 23 Apr 2026 | |||||
| Semaglutide | 2 | 14 Jan 2025 | 23 Jan 2025 | |||||
| CJC-1295 | 4 | 28 Feb 2025 | 20 Mar 2025 | |||||
| Tirzepatide | 6 | 14 Jan 2025 | 20 Mar 2025 | |||||
| BPC-157 | 7 | 14 Jan 2025 | 17 Jul 2025 | |||||
The NextechLabs samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent NextechLabs tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 23 Apr 2026 | Retatrutide | View | 10mg | 9.18mg | -8.2% | 99.90% | (no batch ID) | White Label / Blue Crimp / Clear Cap | Lab E | Public | |
| 9 Oct 2025 | Retatrutide | View | 10mg | 10.1mg | +1.0% | 99.66% | 20240923 | White Label / Blue Crimp / Clear Cap | Lab E | Public | |
| 17 Jul 2025 | BPC-157 | View | 10mg | 10.9mg | +9.0% | 99.26% | 20240923 | No Label / Silver Crimp / Clear Yellow Cap | Lab E | Public | |
| 20 Mar 2025 | BPC-157 | View | 5mg | 7.42mg | +48.4% | 99.68% | 20240923 | White Label / Silver Crimp / Red Cap | Lab B | Finnrick | |
| 20 Mar 2025 | Tirzepatide | View | 30mg | 35.42mg | +18.1% | 99.84% | 2024-09-23 | Blue Label / Silver Crimp / Red Cap | Lab B | Finnrick | |
| 20 Mar 2025 | Ipamorelin | View | 5mg | 6.51mg | +30.2% | 99.73% | 2024-09-23 | Blue Label / Silver Crimp / Clear Cap | Lab B | Finnrick | |
| 20 Mar 2025 | Retatrutide | View | 10mg | 12.63mg | +26.3% | 99.75% | 20240923 | White Label / Silver Crimp / Teal Cap | Lab B | Finnrick | |
Corrections
- 17 Apr 2025: Tirzepatide
- Lab A test 27 Feb 2025, lab C test 28 Feb 2025, lab B test 30 Mar 2025: updated batch claim quantity, label claim was clear, erroneously listed 10mg.
About NextechLabs Test Results From Finnrick
NextechLabs is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 6 products and 31 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud). Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
NextechLabs Testing Activity & Score Summary
In the past 30 days, Finnrick has published no new test results for NextechLabs, and 1 in the past three months. The overall dataset includes 31 tested samples with an average score of 7.0/10 across all products.
Across 31 identity-tested samples, 100% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.7%. Approximately 94% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products:
- Retatrutide (8 tests, 100% identity pass, median purity 99.7%) — Test scores are highly variable, ranging from 6.5 to 9.4 (average 7.6/10), suggesting significant batch-to-batch differences.